Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 437

    1.

    Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study.

    Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM.

    Diabetes Care. 2007 Feb;30(2):325-31.PMID: 17259502 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.

    Nóvoa FJ, Boronat M, Saavedra P, Díaz-Cremades JM, Varillas VF, La Roche F, Alberiche MP, Carrillo A.

    Diabetes Care. 2005 Oct;28(10):2388-93.PMID: 16186268 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.

    Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM.

    Diabetes. 2004 Jun;53(6):1549-55.PMID: 15161760 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Diabetes Care. 2003 Mar;26(3):868-74.PMID: 12610051 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

    Unwin N, Shaw J, Zimmet P, Alberti KG.

    Diabet Med. 2002 Sep;19(9):708-23. Review.PMID: 12207806 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impaired fasting glucose and impaired glucose tolerance in women with prior gestational diabetes are associated with a different cardiovascular profile.

    Pallardo LF, Herranz L, Martin-Vaquero P, Garcia-Ingelmo T, Grande C, Jañez M.

    Diabetes Care. 2003 Aug;26(8):2318-22.PMID: 12882855 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

    Piché ME, Després JP, Pascot A, Nadeau A, Tremblay A, Weisnagel SJ, Bergeron J, Lemieux S.

    Diabet Med. 2004 Jul;21(7):730-7.PMID: 15209766 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impaired fasting glucose is not a risk factor for atherosclerosis.

    Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C.

    Diabet Med. 1999 Mar;16(3):212-8.PMID: 10227566 [PubMed - indexed for MEDLINE]Related articles

    12.

    Elevated white blood cell count in subjects with impaired glucose tolerance.

    Ohshita K, Yamane K, Hanafusa M, Mori H, Mito K, Okubo M, Hara H, Kohno N.

    Diabetes Care. 2004 Feb;27(2):491-6.PMID: 14747234 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.

    Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K.

    Diabetologia. 2008 Feb;51(2):249-57. Epub 2007 Dec 5.PMID: 18060659 [PubMed - indexed for MEDLINE]Related articles

    14.

    Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.

    Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2001 Jan;24(1):39-44.PMID: 11194238 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

    Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.PMID: 15977101 [PubMed - indexed for MEDLINE]Related articles

    16.

    From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000.

    Eschwège E, Charles MA, Simon D, Thibult N, Balkau B.

    Diabetes Care. 2001 Nov;24(11):1945-50.PMID: 11679462 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study.

    Seicean S, Kirchner HL, Gottlieb DJ, Punjabi NM, Resnick H, Sanders M, Budhiraja R, Singer M, Redline S.

    Diabetes Care. 2008 May;31(5):1001-6. Epub 2008 Feb 11.PMID: 18268072 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.

    McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy RP, Savage PJ, Jackson SA.

    J Am Geriatr Soc. 2006 Sep;54(9):1317-24.PMID: 16970637 [PubMed - indexed for MEDLINE]Related articles

    19.

    Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition.

    Vaccaro O, Riccardi G.

    Diabetes Care. 2005 Jul;28(7):1786-8.PMID: 15983335 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.

    Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp DS, Lu GY, Fujimoto W, Yano K.

    Diabetes Care. 1996 Jun;19(6):587-90.PMID: 8725856 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data